VNDA today
$3.95-$0.20 (-4.82%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourAscending Triangle
15 minExpanding
5 minStrong Bearish
Daily trend turns up above $4.11
Key levels
Resistance$4.36
Resistance$4.11
Support$3.85
Support$3.56
Latest news & SEC filings
ProductVanda Pharmaceuticals Activates NEREUS for Miami Art Week
EarningsVanda Pharmaceuticals posts third quarter 2026 financial results
All VNDA news →About Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company that develops and sells prescription medicines. Its marketed products include Fanapt for schizophrenia and bipolar I disorder, HETLIOZ for a rare circadian rhythm sleep-wake disorder and for disrupted nighttime sleep in a genetic developmental condition, PONVORY for relapsing multiple sclerosis, and NEREUS for motion-induced vomiting. It sells mainly in the United States, with additional sales in Europe, Canada and Israel, and also has product candidates in clinical development.
Based on the company's 10-K filed Feb 12, 2026.
Nasdaq · Healthcare
Vanda Pharmaceuticals Inc. (VNDA)
What Is the Price Target for VNDA?
SEPT Low Target
$10.00
SEPT Mid Target
$20.00
SEPT High Target
$20.00
Analyst Consensus
$20.00
Is VNDA a Buy or Sell Right Now?
Thesis
- •Revenue growing 8.7% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VNDA.
Start Free Trial →Is VNDA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$17.12
25
Moat Score
NONE
2/9
Piotroski Score
-0.4
Altman Z-Score
What Is Smart Money Doing with VNDA?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Duncan Charles Cliff | director | Buy | 5,803 | $22K | Nov 5, 2026 |
| Duncan Charles Cliff | director | Buy | 3,447 | $13K | Nov 4, 2026 |
| Duncan Charles Cliff | director | Buy | 750 | $3K | Nov 3, 2026 |
| McGuire Daniel Patrick | officer | Buy | 80,000 | - | Jun 4, 2026 |
| Chrousos Phaedra | director | Buy | 41,600 | - | Jun 4, 2026 |
| Duncan Charles Cliff | director | Buy | 41,600 | - | Jun 4, 2026 |
| DUGAN RICHARD W | director | Buy | 41,600 | - | Jun 4, 2026 |
| Ward Anne Sempowski | director | Buy | 41,600 | - | Jun 4, 2026 |
| Honore Tage | director | Buy | 41,600 | - | Jun 4, 2026 |
| Mitchell Stephen Ray | director | Buy | 41,600 | - | Jun 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →VNDA Growth Story
Revenue YoY
8.7%
3yr Revenue CAGR
-5.3%
EPS Growth YoY
-1033.33%
FCF Growth YoY
-579.8%
Revenue Trend
ACCELERATING
Dark Pool Trades for VNDA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for VNDA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 24:46:28 | $4.01 | 1,000 | $$4K | BUY |
| 21:00:22 | $3.95 | 1,600 | $$6K | SELL |
| 21:00:22 | $3.95 | 1,295 | $$5K | SELL |
| 21:00:22 | $3.95 | 1,900 | $$8K | SELL |
| 21:00:22 | $3.95 | 6,900 | $$27K | SELL |
5 dark pool trades shown · $$50K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for VNDA
PREVIEWSEPT Investing provides real-time options flow tracking for VNDA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $7 | Dec 18 | 36 | $$30 | 2 | SWEEP |
1 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Vanda Pharmaceuticals Inc. (VNDA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →VNDA — frequently asked questions
What is VNDA stock price today?
Vanda Pharmaceuticals Inc. (VNDA) is at $3.95, down 4.82% (-$0.20) at the Nov 12, 2026 close.
Why is VNDA stock moving today?
Latest VNDA news — Nov 11, 2026: Vanda Pharmaceuticals Activates NEREUS for Miami Art Week · Oct 29, 2026: Vanda Pharmaceuticals posts third quarter 2026 financial results
What is the VNDA price target?
The average analyst price target for VNDA is $20.00, ranging from $10 to $20, based on 3 analysts.
What do analysts rate VNDA?
Analyst ratings for VNDA: 0 Buy, 5 Hold, 0 Sell — consensus Hold.
Did VNDA beat earnings?
VNDA last reported on Oct 28, 2026: EPS -$0.37 vs -$0.68 expected — a beat of 45.7%.
Does VNDA pay a dividend?
VNDA does not currently pay a dividend.
What are VNDA support and resistance levels?
Support: $3.85, $3.56. Resistance: $4.11, $4.36, $4.64.
What are insiders doing with VNDA?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on VNDA?
Nov 11, 2026: Vanda Pharmaceuticals Activates NEREUS for Miami Art Week · Oct 29, 2026: Vanda Pharmaceuticals posts third quarter 2026 financial results